CryoPort Inc (CYRX) Q3 2024 Earnings Call Highlights: Strong Service Growth Amid Market Challenges [Yahoo! Finance]
CryoPort, Inc. (CYRX)
NASDAQ:AMEX Investor Relations:
ir.cryoport.com
Company Research
Source: Yahoo! Finance
Gross Margin for Life Science Services: Improved to 46%. Full Year Revenue Guidance: Maintained at $225 million to $235 million. Adjusted EBITDA and Cash Flow: Positive through the quarter. CRYOPDP New Contracts: Nine high-value contracts with a total value of over $6 million per year. Global Clinical Trials Supported: Total of 691, a net increase of 21 clinical trials over last year. Warning! GuruFocus has detected 6 Warning Signs with CYRX. Release Date: November 07, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript CryoPort Inc ( NASDAQ:CYRX ) reported a 9% growth in its life sciences services business for the third quarter, with BioStorage and BioServices revenue increasing over 12% compared to last year. The company maintained its full-year revenue guidance of $225 million to $235 million, indicating confidence in continued growth despite market challenges. CryoPort Inc ( NASDAQ:CYRX ) launched its Integr
Show less
Read more
Impact Snapshot
Event Time:
CYRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CYRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CYRX alerts
High impacting CryoPort, Inc. news events
Weekly update
A roundup of the hottest topics
CYRX
News
- Cryoport, Inc. (NASDAQ: CYRX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $11.00 price target on the stock.MarketBeat
- Cryoport Expands IntegriCellâ„¢ Cryopreservation Services Solution with Opening of New Center of Excellence in EuropePR Newswire
- Cryoport, Inc. (NASDAQ: CYRX) had its price target lowered by analysts at Roth Mkm from $18.00 to $15.00. They now have a "buy" rating on the stock.MarketBeat
- Cryoport Reports Third Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Cryoport Reports Third Quarter 2024 Financial ResultsPR Newswire
CYRX
Earnings
- 11/7/24 - Beat
CYRX
Sec Filings
- 12/13/24 - Form 4
- 12/4/24 - Form 4
- 12/2/24 - Form 4
- CYRX's page on the SEC website